Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
ONCTERNAL THERAPEUTICS INC
About ONCT
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of oncology therapies for the treatment of patients with cancers that have critical unmet medical needs. The Company’s product candidates include ONCT-534, ONCT-808, Zilovertamab, and ONCT-216. ONCT-534 is a dual-action androgen receptor inhibitor (DAARI), for the treatment of advanced castration-resistant prostate cancer (CRPC) and other androgen receptor (AR) driven diseases. ONCT-808 is an autologous chimeric antigen receptor (CAR-T) therapy that targets ROR1 for the treatment of hematologic malignancies and solid tumors. Zilovertamab is an investigational, humanized, monoclonal antibody designed to inhibit the function of Receptor tyrosine kinase-like Orphan Receptor 1 (ROR1). Zilovertamab has been evaluated in an investigator-initiated Phase 1b study of zilovertamab in combination with docetaxel in patients with mCRPC.
Find out what a historical investment in ONCTERNAL THERAPEUTICS INC would be worth today using our ONCT stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy ONCT shares in Australia?
Buying ONCT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in ONCTERNAL THERAPEUTICS INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ONCT
What is the ticker symbol of ONCTERNAL THERAPEUTICS INC?
The ticker symbol for ONCTERNAL THERAPEUTICS INC is ONCT.
How much is one share of ONCT?
One share of ONCT is valued at $0.57 as of 20 May 2026.
What is the market capitalisation of ONCTERNAL THERAPEUTICS INC ONCT?
As of 20 May 2026 ONCTERNAL THERAPEUTICS INC has a market cap of -.
What is the 52-week high for ONCTERNAL THERAPEUTICS INC stock?
The ONCTERNAL THERAPEUTICS INC 52-week high stock price is $NaN.
What is the 52-week low for ONCTERNAL THERAPEUTICS INC stock?
The ONCTERNAL THERAPEUTICS INC 52-week low stock price is $NaN.
Can I buy ONCT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ONCT shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ONCT on Stake
- Buy ONCT from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ONCT from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ONCT related stocks